Feature | March 31, 2014

ACC, AHA, SCAI Publish Structured Reporting Initiative to Standardize and Improve Patient Care

New health policy statement supports efforts to improve effectiveness, communication and coordination

March 31, 2014 — Led by members of the American College of Cardiology (ACC), American Heart Association (AHA) and Society for Cardiovascular Angiography and Interventions (SCAI), 14 professional societies from across the world have developed a health policy statement that defines the clinical standards for structured reporting in the cardiac catheterization suite. The statement was published online last week in the Journal of the American College of Cardiology and Circulation.

The goal of structured reporting is to produce clear, concise, thorough and organized reports on catheterization procedures that include all information relevant to both clinical care and operational administration. For instance, it should include a minimum dataset that anticipates clinical, operational, regulatory and financial uses, and documents indications and appropriateness.

The result of this approach should be data-intensive reports that concisely and efficiently convey the details of a variety of catheterization procedures, such as those involving the heart and carotid arteries, peripheral blood vessels, pediatric and adult congenital and structural heart conditions, and valve replacements. The clarity, consistency and quality of these procedure reports will be a marked improvement over current approaches, which are inconsistent and vary widely among catheterization labs and vendors.

“Getting everyone on the same page is crucial to improving care for the patient,” said Tim Sanborn, M.D., MS, FACC, FAHA, FSCAI, clinical professor of medicine, University of Chicago Pritzker School of Medicine, and project chair. “Structured reporting increases the efficiency and effectiveness of the entire catheterization team, improves communication and coordination of care, and reduces delays in care. In addition, it facilitates the use of data for clinical care, quality assessment, performance improvement, billing, regulatory and other purposes.”

The new published statement offers specific report templates to illustrate the principles of structured reporting. These templates help users manage the patient’s data before, during and after the procedure and integrate data management into the workflows of all care team members. They provide a step-by-step process from scheduling to analysis and outline how to compile a report once the procedure is complete. They also identify when, where and how the processes of data are integrated into the workflow.

“These data-intense reports will efficiently convey the details of the procedure, findings, analyses and recommendations of care for the patient,” said James E. Tcheng, M.D., FACC, FSCAI, FESC, interventional cardiologist, director of Duke Information Systems for cardiovascular care, Duke University Health System, Durham, N.C., and vice chair of the project. “They will reduce the documentation burden and allow physicians to focus more on care recommendations for the patient.”

Widespread adoption of this structured reporting approach will require a substantial transformation of catheterization laboratory reporting that will affect administration, physicians and staff. This transformation, however, is aligned with federal initiatives promoting the universal adoption of electronic health records (EHRs).

In providing report templates, the joint effort will help accelerate the development and application of this new approach to reporting catheterization procedures. Yet also critical to the success of this effort is for health information technology vendors to build and implement systems that enable structured reporting.

For more information: www.cardiosource.org, www.americanheart.org, www.scai.org, www.hl7.org, www.ihe.net, www.sts.org and www.vascularweb.org

Related Content

Lumedx, CVIS, Baylor Scott & White Health, BHVH, Texas
News | Cardiac PACS| January 17, 2017
Lumedx Corp. recently announced that it has implemented Phase 1 of a long-term, multiphase cardiovascular information...
Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable| January 17, 2017 | Dave Fornell
One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers
Medtronic, CoreValve Evolut R TAVR system, U.S. IDE Study, TCT 2016
News | Heart Valve Technology| November 03, 2016
Medtronic plc unveiled new clinical data showing that patients treated with the self-expanding CoreValve Evolut R...
congenital heart patients, cardiac cath lab, anesthesia sedation practices, joint document, SCAI, SPA, CCAS
News | Congenital Heart| November 03, 2016
The Society for Cardiovascular Angiography and Interventions (SCAI), the Society for Pediatric Anesthesia (SPA) and the...
open-heart surgery, PCI, percutaneous coronary intervention, NOBLE trial, left main coronary artery disease, LMCAD, TCT 2016
News | Cardiovascular Surgery| November 03, 2016
Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients with left main...
SENTINEL trial, transcatheter embolic protection, TCEP, TAVR, stroke, TCT 2016
News | Embolic Protection Devices| November 03, 2016
An international study has found that transcatheter cerebral embolic protection (TCEP) is safe, provides effective...
News | Drug-Eluting Balloons| November 03, 2016
The Spectranetics Corp. announced that it has submitted to the U.S. Food & Drug Administration (FDA) its Pre-Market...
RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders| November 02, 2016
St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First Report session at the...
Medtronic, Resolute Integrity DES, drug-eluting stent, BIO-RESORT study, TCT 2016
News | Stents Drug Eluting| November 02, 2016
Investigators recently unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers...
Medtronic, Harmony TPV, transcatheter pulmonary valve, clinical study results, TCT 2016
News | Heart Valve Technology| November 02, 2016
Medtronic plc recently announced new clinical data for the Harmony Transcatheter Pulmonary Valve (TPV) from its early...
Overlay Init